AU7516494A - Oligomers for modulating human immunodeficiency virus - Google Patents

Oligomers for modulating human immunodeficiency virus

Info

Publication number
AU7516494A
AU7516494A AU75164/94A AU7516494A AU7516494A AU 7516494 A AU7516494 A AU 7516494A AU 75164/94 A AU75164/94 A AU 75164/94A AU 7516494 A AU7516494 A AU 7516494A AU 7516494 A AU7516494 A AU 7516494A
Authority
AU
Australia
Prior art keywords
oligomers
immunodeficiency virus
human immunodeficiency
modulating human
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75164/94A
Inventor
David J Ecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of AU7516494A publication Critical patent/AU7516494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16311Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
AU75164/94A 1993-07-29 1994-07-28 Oligomers for modulating human immunodeficiency virus Abandoned AU7516494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9971893A 1993-07-29 1993-07-29
US099718 1993-07-29
PCT/US1994/008517 WO1995004068A1 (en) 1993-07-29 1994-07-28 Oligomers for modulating human immunodeficiency virus

Publications (1)

Publication Number Publication Date
AU7516494A true AU7516494A (en) 1995-02-28

Family

ID=22276300

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75164/94A Abandoned AU7516494A (en) 1993-07-29 1994-07-28 Oligomers for modulating human immunodeficiency virus

Country Status (2)

Country Link
AU (1) AU7516494A (en)
WO (1) WO1995004068A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
AU3689695A (en) * 1994-09-29 1996-04-19 Nauchno-Proizvodstvennoe Predpriyatie "Farmek" Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid
JP2001518054A (en) * 1995-06-07 2001-10-09 パーセプティブ バイオシステムズ,インコーポレーテッド PNA-DNA chimera and PNA synthon for chimera synthesis
US6015710A (en) * 1996-04-09 2000-01-18 The University Of Texas System Modulation of mammalian telomerase by peptide nucleic acids
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
AU754242B2 (en) * 1997-04-28 2002-11-07 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
JP2004283024A (en) * 2003-03-19 2004-10-14 Junsei Chemical Co Ltd New antisense oligonucleotide and anti-hiv agent
DE10344799A1 (en) * 2003-09-26 2005-04-14 Ganymed Pharmaceuticals Ag Identification of surface-associated antigens for tumor diagnosis and therapy

Also Published As

Publication number Publication date
WO1995004068A1 (en) 1995-02-09

Similar Documents

Publication Publication Date Title
AU5726694A (en) Human immunodeficiency virus decoy
AU3802493A (en) Surgical endoclip
AU696232B2 (en) Syringe
AU4944093A (en) Osteosynthesis aid
AU8096994A (en) Safety syringe
AU4525193A (en) Retractable-bladed surgical scalpel
AU3434393A (en) Targeted virus
AU3421793A (en) Externally updatable rom (eurom)
AU7045594A (en) Surgical stockinette
AU7085594A (en) Syringe
AU4514193A (en) Bone formation-inducing protein
AU4682693A (en) Disposable tourniquet
AU7973994A (en) Combination therapy for hiv infection
AU4579893A (en) Bone materials
AU5182593A (en) N,N-disubstituted arylcycloalkylamines
AU6507994A (en) Disposable external fixator
AU3724093A (en) Vaccinal polypeptides
AU7516494A (en) Oligomers for modulating human immunodeficiency virus
AU7523794A (en) Oligomers for modulating viral processes
AU6715094A (en) Recombinant vaccine
AU4840893A (en) Surgical apparatus
AU6161794A (en) Peptides having anti-hiv activity
AU6511294A (en) Tonometer
AU7701794A (en) Safety syringe
AU8049694A (en) Simplified safety syringe